Type A thymoma
Definition
An
organotypic tumour composed of bland spindle or oval cells.
Lymphocytes are sparse or absent. It is thought to be derived from
thymic medullary epithelial cells, as evidenced by positivity for CD20,
PE-35
and metallothionein.
Synonyms
Spindle
cell thymoma, medullary thymoma.
Epidemiology
This type is
relatively uncommon, accounting for 4% to19% of all thymomas1.
Mean age at presentation is about 60 years. Cases in children have
been reported1.
Clinical features
25% of type A
thymomas are associated with myasthenia gravis. There may be pure red
cell aplasia4.
Macroscopic appearances
Type
A thymomas are usually Masaoka stage I2.
They are well circumscribed
and encapsulated but with only vague lobulation. They may
be cystic.
Histopathology
These
tumours are encapsulated,
although there may be invasion through the capsule and, rarely,
infiltration of the lung. Distinct lobulation and dissecting fibrous
bands are absent.
The
tumour cells are spindle
or oval, the latter sometimes predominating. Nuclei are bland with
dispersed to coarse chromatin and inconspicuous nucleoli. The spindle
cells may be short and arranged in a haemangiopericytomatous pattern;
alternatively, they may be long, resembling fibroblasts and taking on
an interlacing or storiform pattern4.
They may form glandular structures, rosettes (without a central
lumen) or glomeruloid bodies, often immediately beneath the tumour
capsule. There may be papillary projections into cystic spaces or
meningioma-like whorls. Reticulin surrounds individual tumour cells.
Few vessels are present. Vessels may form a haemangiopericytomatous
pattern. Mitoses are rare. Formation of Hassall corpuscles is rare.
Palisading around perivascular spaces is NOT a feature2.
Infarction may occur.
There
are few, or no, lymphocytes, except where there are foci of spindle
cell micronodules in a lymphoid stroma. In particular, immature
T-cells are lacking.
Rare
spindle cell thymomas show nuclear hyperchromasia, pleomorphism and
necrosis. It is not clear whether these are poorly differentiated
cases of type A thymoma, spindle cell variants of type
B3 thymoma or spindle cell type
C thymoma / thymic carcinomas2.
Rarely, there is transformation to thymic carcinoma: a focus of
transformation may show necrosis.
Immunohistochemistry
|
Epithelial cells |
|
|
AE1 |
positive0,1 |
|
AE3 |
negative0,1 |
CK20 |
negative0,1 |
CD5 |
negative0,1 |
CD20 |
focally positive0,2, 8/21
(short spindle cell variant)4,
7/10 (long
spindle cell variant)4 |
bcl-2 |
negative or only focally positive0,1 |
CD57 |
variable/focal0,1,
80% of cases |
EMA |
negative or only focally positive0,1 |
metallothionein |
positive0,1 |
PE-35 |
positive (long spindle cells may be negative) 0,3 |
laminin |
surrounds individual cells0,1 |
type IV collagen |
surrounds individual cells0,1 |
UH-1 |
0/2 |
ERa |
H score = 111±105 |
PR-B |
H score = 86±165 |
p53 |
negative or low expression0,1 |
Ki-67 |
negative or low expression0,1 |
|
|
|
|
|
Lymphocytes (if present) |
|
CD3 |
positive0,1,4 |
CD5 |
positive0,1 |
CD1a |
minority of T-cells0,1,2,
majority of T-cells4 |
CD99 |
minority of T-cells0,1,2 |
CD20 |
negative, except in micronodular areas with a lymphoid stroma0,1 |
|
|
|
|
Cytogenetics
t(15;22)(p11;q11)
and deletions of chromosome 6p have been reported0,1.
There is loss of heterozygocity at 6q23.3-25.3, a feature
shared with type B3 thymomas and squamous cell thymic carcinomas0.
Differential diagnosis
Management
Surgical removal, if
complete, is almost always curative.
Prognosis
Type
A thymomas do not recur if fully excised. The prognosis is excellent:
100% survival at 10 years. Even advanced tumours may show slow progression1.
Exceptional cases of distant
metastases or malignant
transformation to thymic carcinoma have occurred.
References
0 Tumours of the Lung, Pleura, Thymus and Heart. WHO
Classification of Tumours. IARC Press 2004.
1 J Rosai
et al. Histological typing of tumours of the thymus. WHO
International histological classification of tumours. Springer-Verlag,
second edition, 1999.
2
Muller-Hermelink, H. K. and A. Marx (1999). "Pathological
aspects of malignant and benign thymic disorders." Ann Med 31
Suppl 2: 5-14.
3
Hattori, H., H. Tateyama, et al. (2000). "PE-35-related antigen
expression and CD1a-positive lymphocytes in thymoma subtypes based on
Muller-Hermelink classification.An immunohistochemical study using
catalyzed signal amplification." Virchows Arch 436(1): 20-7.
4
Pan, C. C., W. Y. Chen, et al. (2001). "Spindle cell and mixed
spindle/lymphocytic thymomas: an integrated clinicopathologic and
immunohistochemical study of 81 cases." Am J Surg Pathol 25(1): 111-20.
5
Ishibashi, H., T. Suzuki, et al. (2003). "Sex steroid hormone
receptors in human thymoma." J Clin Endocrinol Metab 88(5): 2309-17.
This page last
revised 4.1.2006.
©SMUHT/PW Bishop